NVP Associates, LLC
In its 13F for Q3 2024 (holdings as of September 30, 2024, filed November 12, 2024), NVP Associates, LLC reported 8 stock positions worth $176.1 million. Its top holding was MBX Biosciences (MBX) at 31.5% of the portfolio, followed by Zenas Biopharma (ZBIO, 17.7%) and Talkspace (TALK, 17.4%). Compared with Q2 2024, it opened 2 new positions. The biggest buy was a new position in MBX Biosciences (MBX).
- Most Recent 13F
- Q2 2026
- Location
- MENLO PARK, CA
- CIK
- 0001545692
- Portfolio Value
- $176.1M (Q3 2024)
- SEC Filing
- 0001104659-24-116813 ↗ filed Nov 12, 2024
Holdings Value
Holdings 8 stocks · $176.1M
| MBX MBX Biosciences Inc. | 31.51% | 2,136,335 | $55.5M | New |
| ZBIO Zenas Biopharma Inc. | 17.66% | 1,838,482 | $31.1M | New |
| TALK Talkspace Inc. | 17.45% | 14,702,972 | $30.7M | No change |
| DAVE Dave Inc. | 13.22% | 582,675 | $23.3M | No change |
| UDMY Udemy Inc. | 13.16% | 3,114,732 | $23.2M | No change |
| OPEN Opendoor Technologies Inc. | 4.76% | 4,189,562 | $8.4M | No change |
| GROV Grove Collaborative Holdings | 2.26% | 2,943,522 | $4.0M | No change |
| DIGITAL BRANDS GROUP INC | 0.00% | 636 | $214 | No change |
Portfolio Sells Q2 2024 → Q3 2024
| None this quarter. | |||
Portfolio Buys Q2 2024 → Q3 2024
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 7 | $328.2M | MBX, AVLN, OMDA, ZBIO, SNOW |
| Q1 2026 | 5 | $176.2M | MBX, BLLN, ZBIO, OMDA, GROV |
| Q4 2025 | 6 | $255.2M | MBX, ZBIO, BLLN, OMDA, TALK |
| Q3 2025 | 5 | $166.1M | OMDA, ZBIO, MBX, TALK, GROV |
| Q2 2025 | 7 | $184.2M | DAVE, OMDA, TALK, MBX, ZBIO |
| Q1 2025 | 6 | $112.2M | DAVE, TALK, MBX, ZBIO, GROV |
| Q4 2024 | 7 | $186.9M | DAVE, TALK, MBX, UDMY, ZBIO |
| Q3 2024 | 8 | $176.1M | MBX, ZBIO, TALK, DAVE, UDMY |
| Q2 2024 | 6 | $91.3M | TALK, UDMY, DAVE, OPEN, GROV |
| Q1 2024 | 6 | $125.9M | TALK, UDMY, DAVE, OPEN, GROV |